| Literature DB >> 25988763 |
Marie-Ève Riou1, Simon Jomphe-Tremblay2, Gilles Lamothe3, Dawn Stacey4,5, Agnieszka Szczotka6, Éric Doucet7.
Abstract
Weight loss from exercise-induced energy deficits is usually less than expected. The objective of this systematic review was to investigate predictors of energy compensation, which is defined as body energy changes (fat mass and fat-free mass) over the total amount of exercise energy expenditure. A search was conducted in multiple databases without date limits. Of 4745 studies found, 61 were included in this systematic review with a total of 928 subjects. The overall mean energy compensation was 18% ± 93%. The analyses indicated that 48% of the variance of energy compensation is explained by the interaction between initial fat mass, age and duration of exercise interventions. Sex, frequency, intensity and dose of exercise energy expenditure were not significant predictors of energy compensation. The fitted model suggested that for a shorter study duration, lower energy compensation was observed in younger individuals with higher initial fat mass (FM). In contrast, higher energy compensation was noted for younger individuals with lower initial FM. From 25 weeks onward, energy compensation was no longer different for these predictors. For studies of longer duration (about 80 weeks), the energy compensation approached 84%. Lower energy compensation occurs with short-term exercise, and a much higher level of energy compensation accompanies long-term exercise interventions.Entities:
Keywords: body composition; energy compensation; exercise intervention
Mesh:
Year: 2015 PMID: 25988763 PMCID: PMC4446773 DOI: 10.3390/nu7053677
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Criteria of included and excluded items for study selection. FFM, fat-free mass; FM, fat mass; EE, energy expenditure; NSPA, non-structured physical activity.
| Criteria | Included | Excluded |
|---|---|---|
| Population | Men and Women | Under 18 or over 55 years old |
| Focus/intervention | Aerobic training | Yoga |
| Outcomes | Body weight | Maximal heart rate |
| FFM | ||
| FM | ||
| EE | ||
| VO2max reserve | ||
| Maximal heart rate reserve | ||
| Study design | RCTs | |
| Language | English | Other languages |
| Publication status | Published articles (including all years) | Unpublished articles |
Characteristics of included studies and baseline participants (n = 61).
| Studies | Studies Characteristics |
| Participants Characteristics at Baseline | ||||||
|---|---|---|---|---|---|---|---|---|---|
| First Author | Year | Group Design | Inclusion | Sex | Sedentary | Stable Body Weight | VO2peak (mL/kg/min) | Age (year) | Weight (kg) |
| Abe [ | 1997 | RCT | 9 | female | Yes | N/A | N/A | 19–23 | 54.5 ± 4.9 (9) |
| Blaney [ | 1991 | Before-after | 7 | male | Yes | N/A | 32.4 ± N/A | 42.0 ± 6.0 | 91.0 ± 15.0 (7) |
| Brandon [ | 2006 | RCT | 28 | female | Yes | Yes | 32.0 ± N/A | 37.3 ± N/A | 85.6 ± N/A (28) |
| Carter [ | 2001 | Before-after | 8 | male | N/A | N/A | 41.5 ± 6.7 | 22.0 ± 1.0 | 78.1 ± 7.2 (8) |
| Carter [ | 2001 | Before-after | 8 | female | N/A | N/A | 31.9 ± 3.9 | 22.0 ± 2.0 | 68.2 ± 7.0 (8) |
| Caudwell [ | 2013 | ITS | 35 | male | Yes | Yes | 34.9 ± 6.9 | 41.3 ± 8.6 | 96.9 ± 13.2 (35) |
| Caudwell [ | 2013 | ITS | 72 | female | Yes | Yes | 29.1 ± 6.5 | 40.6 ± 9.5 | 85.9 ± 11.5 (72) |
| Cowan [ | 1985 | RCT | 16 | female | Yes | N/A | N/A | 41.3 ± 4.4 | 67.5 ± 11.2 (16) |
| Cramer [ | 1991 | RCT | 25 | female | N/A | N/A | 25.7 ± 0.9 | 36.0 ± 1.6 | 76.5 ± 1.9 (18) |
| Després [ | 1991 | Before-after | 13 | female | N/A | N/A | 24.3 ± N/A | 38.8 ± 5.3 | 90.0 ± 11.8 (13) |
| Donnelly [ | 2000 | ITS | 11 | female | Yes | N/A | 23.6 ± 2.8 | 54.0 ± 9.0 | 81.4 ± 5.7 (11) |
| Donnelly [ | 2000 | ITS | 11 | female | Yes | N/A | 22.9 ± 4.1 | 49.0 ± 8.0 | 85.9 ± 13.1 (11) |
| Donnelly [ | 2013 | RCT | 32 | female | N/A | N/A | 31.6 ± 3.8 | 22.6 ± 3.2 | 81.3 ± 13 (18) |
| Donnelly [ | 2013 | RCT | 31 | female | N/A | N/A | 29.8 ± 4.1 | 22.6 ± 2.9 | 83.3 ± 18.9 (19) |
| Donnelly [ | 2013 | RCT | 30 | male | N/A | N/A | 36.4 ± 6.4 | 23.3 ± 3.7 | 102. 0 ± 11.7 (19) |
| Donnelly [ | 2013 | RCT | 22 | male | N/A | N/A | 37.1 ± 6.5 | 23.5 ± 3.2 | 99.9 ± 19.4 (18) |
| Dowdy [ | 1985 | Before-after | 18 | female | Yes | N/A | 33.8 ± 3.9 | 31.5 ± 5.6 | 63.4 ± 7.2 (18) |
| Earnest [ | 2013 | Before-after | 21 | male | Yes | N/A | 29.5 ± 2.9 | 48.0 ± 9.0 | 93.9 ± 9.6 (21) |
| Earnest [ | 2013 | Before-after | 21 | male | Yes | N/A | 28.3 ± 4.5 | 49.0 ± 9.0 | 98.9 ± 12.7 (16) |
| Glisezinski [ | 2003 | Before-after | 11 | male | N/A | Yes | 34.3 ± 1.3 | 25.6 ± 1.4 | 89.5 ± 1.6 (11) |
| Glowacki [ | 2004 | RCT + ITS | N/A | male | Yes | N/A | 40.8 ± 9.0 | 25.0 ± 5.0 | 87.9 ± 16.6 (12) |
| Grediagin [ | 1995 | Before-after | 9 | female | Yes | Yes | 31.5 ± 3.8 | 30.0 ± 5.0 | 68.2 ± 5.9 (6) |
| Grediagin [ | 1995 | Before-after | 9 | female | Yes | Yes | 31.3 ± 3.3 | 31.0 ± 6.0 | 68.6 ± 4.6 (6) |
| Hardman [ | 1992 | ITS | 34 | female | Yes | N/A | N/A | 44.9 ± 1.5 | 64.0 ± 1.7 (28) |
| Hinkleman [ | 1993 | RCT | 25 | female | N/A | N/A | 25.7 ± 0.9 | 36.0 ± 1.6 | 76.5 ± N/A (18) |
| Juneau [ | 1987 | RCT | 30 | male | Yes | N/A | 31.9 ± 4.4 | 49.0 ± 6.0 | 79.4 ± 11.0 (28) |
| Juneau [ | 1987 | RCT | 30 | female | Yes | N/A | 25.8 ± 3.9 | 47.0 ± 5.0 | 63.8 ± 8.0 (24) |
| Kirk [ | 2003 | RCT | N/A | female | Yes | N/A | 32.8 ± 4.2 | 24.0 ± 5.0 | 77.0 ± 11.4 (25) |
| Kirk [ | 2003 | RCT | N/A | male | Yes | N/A | 39.2 ± 5.2 | 22.0 ± 4.0 | 94.0 ± 12.6 (16) |
| Krustrup [ | 2010 | RCT | 25 | female | Yes | N/A | 32.7 ± 1.1 | 37.0 ± 2.0 | 71.6 ± 2.3 (21) |
| Krustrup [ | 2010 | RCT | 25 | female | Yes | N/A | 35.5 ± 1.4 | 37.0 ± 1.0 | 67.1 ± 1.8 (17) |
| Krustrup [ | 2009 | RCT | 13 | male | Yes | N/A | 39.6 ± 1.5 | 30.0 ± 2.0 | 82.2 ± 2.9 (12) |
| Krustrup [ | 2009 | RCT | 12 | male | Yes | N/A | 39.3 ± 2.5 | 31.0 ± 2.0 | 85.8 ± 5.5 (10) |
| Lee [ | 2009 | RCT | 10 | male | N/A | Yes | 46.2 ± 1.2 | 26.2 ± 1.4 | 73.8 ± 2.1 (9) |
| Moro [ | 2005 | Before-after | 10 | male | N/A | Yes | 34.7 ± 1.2 | 26.0 ± 1.4 | 90.3 ± 1.6 (10) |
| Mougios [ | 2006 | Before-after | 7 | female | Yes | Yes | 36.6 ± 3.8 | 30.0 ± 9.0 | 64.1 ± 6.3 (7) |
| Mougios [ | 2006 | Before-after | 7 | female | Yes | Yes | 34.0 ± 5.6 | 31.0 ± 9.0 | 68.7 ± 8.7 (7) |
| Nishida [ | 2010 | Before-after | 6 | male | Yes | N/A | 41.3 ± 2.0 | 24.5 ± 1.9 | 66.4 ± 3.5 (6) |
| Nordby [ | 2012 | RCT | 17 | male | Yes | Yes | 38.2 ± 1.7 | 28.0 ± 1.0 | 94.5 ± 2.3 (12) |
| Nybo [ | 2010 | Before-after | 9 | male | Yes | N/A | 39.3 ± 2.5 | 31.0 ± 2.0 | 85.8 ± 5.5 (9) |
| Polak [ | 2006 | Before-after | 25 | female | Yes | Yes | 24.6 ± 3.9 | 40.4 ± 6.7 | 88.5 ± 8.2 (25) |
| Rosenkilde [ | 2012 | RCT | 21 | male | Yes | Yes | 34.6 ± 4.1 | 30.0 ± 7.0 | 93.2 ± 8.1 (18) |
| Rosenkilde [ | 2012 | RCT | 22 | male | Yes | Yes | 36.2 ± 5.3 | 28.0 ± 5.0 | 91.3 ± 7.2 (18) |
| Ruby [ | 1996 | Before-after | 6 | female | Yes | N/A | 39.9 ± 1.2 8 | 20.3 ± 0.9 | 58.2 ± 3.3 (6) |
| Ruby [ | 1996 | Before-after | 6 | female | Yes | N/A | 33.6 ± 0.2 8 | 20.5 ± 1.0 | 61.6 ± 3.6 (6) |
| Ruby [ | 1996 | Before-after | 6 | female | Yes | N/A | 36.8 ± 1.4 8 | 21.3 ± 0.6 | 62.4 ± 3.0 (6) |
| Santiago [ | 1995 | RCT | 21 | female | Yes | N/A | 31.5 ± 4.2 | 30.1 ± 5.3 | 64.4 ± 10.2 (16) |
| Sedlock [ | 2010 | RCT | 10 | male | N/A | Yes | 46.2 ± 1.2 | 26.2 ± 1.4 | 73.8 ± 2.1 (9) |
| Sijie [ | 2012 | RCT | 20 | female | N/A | N/A | 33.3 ± 3.9 | 19.8 ± 1.0 | 73.7 ± 7.5 (17) |
| Sijie [ | 2012 | RCT | 20 | female | N/A | N/A | 32.9 ± 4.7 | 19.3 ± 0.7 | 74.2 ± 9.0 (16) |
| Snyder [ | 1997 | Before-after | 15 | female | Yes | Yes | 24.0 ± 4.6 | 43.0 ± 11.0 | 87.2 ± 21.5 (13) |
| Suter [ | 1995 | Before-after | 20 | male | Yes | N/A | 39.3 ± 5.5 | 39.1 ± 8.3 | 75.6 ± 9.8 (12) |
| Tan [ | 2012 | RCT | 30 | female | Yes | N/A | 34.1 ± 2.6 | 20–23 | 70.4 ± 5.3 (29) |
| Trapp [ | 2008 | RCT | 15 | female | Yes | N/A | 28.8 ± 2.1 | 22.4 ± 0.7 | 63.3 ± 3.8 (11) |
| Trapp [ | 2008 | RCT | 15 | female | Yes | N/A | 30.9 ± 2.1 | 21.0 ± 0.8 | 59.8 ± 2.4 (8) |
| Van Aggel-Leijssen [ | 2002 | RCT | 8 | male | Yes | Yes | 31.1 ± N/A | 43.4 ± 6.3 | 102.7 ± 10.8 (8) |
| Van Aggel-Leijssen [ | 2002 | RCT | 8 | male | Yes | Yes | 31.4 ± N/A | 40.0 ± 6.3 | 105.5 ± 6.6 (8) |
| Van Aggel-Leijssen [ | 2001 | Before-after | 8 | female | Yes | Yes | 24.7 ± N/A | 32.8 ± 9.6 | 91.2 ± 9.7 (8) |
| Van Aggel-Leijssen [ | 2001 | RCT | 7 | female | Yes | Yes | 24.6 ± N/A | 37.7 ± 6.4 | 86.5 ± 10.2 (7) |
| Wilmore [ | 1980 | RCT | 9 | male | Yes | N/A | 38.6 ± N/A | 37.0 ± 8.9 | 85.7 ± 18.9 (9) |
| Wilmore [ | 1980 | RCT | 9 | male | Yes | N/A | 42.2 ± N/A | 35.6 ± 8.3 | 79.8 ± 8.9 (9) |
The values are the mean ± SD or presented as a range. The number in parentheses represents the number of participants tested. Notes. RCT, randomised controlled trial; ITS, interrupted time series; 1 trial registration: ISRCTN47291569; 2 trial registration: PBRC29018; 3 trial registration: NCT01090869; 4 trial registration: NCT01430143.
Characteristics of the intervention and the outcomes (n = 61). ExEE, exercise EE.
| Studies | Interventions Characteristics | Outcomes of the Interventions | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| First Author, year | Supervised | Compliance (%) | Exercise Intervention | Measure of BC | FM (Initial) (kg) | FM (Final) (kg) | FFM (Initial) (kg) | FFM (Final) (kg) | ExEE Total (kcal) | Compensation (%) |
| Abe, 1997 [ | Yes | N/A | 2.8×/week for 30 min during 13 weeks of continuous biking at 50%–60% HRRmax | HW | 15.3 ± 2.7 (9) | 12.7 ± 2.1 (9) | 39.2 ± 3.3 (9) | 38.5 ± 3.4 (9) | 7280 | −245 |
| Blaney, 1991 [ | No | N/A | 3×/week for 28 min during 16 weeks of continuous running/walking at 70%–80% VO2max | HW | 25.5 ± N/A (7) | 23.7 ± N/A (7) | 65.0 ± 10.0 (7) | 67.0 ± 10.0 (7) | 16,131 | 14 |
| Brandon, 2006 [ | No | 87.6 | 3×/week for 50 min during 18 weeks of continuous brisk walking at a self-pace with an objective of 3.5 mph | DEXA | 38.5 ± N/A (28) | 36.1 ± N/A (28) | 47.1 ± N/A (28) | 47.6 ± N/A (28) | 17,521 | −24 |
| Carter, 2001 [ | No | N/A | 5×/week for 60 min during 7 weeks of continuous biking at 60% VO2peak | DEXA | 12.2 ± N/A (8) | 11.8 ± N/A (8) | 65.9 ± 7.1 (8) | 66.0 ± 6.6 (8) | 22,191 | 84 |
| Carter, 2001 [ | No | N/A | 5×/week for 60 min during 7 weeks of continuous biking at 60% VO2peak | DEXA | 17.9 ± N/A (8) | 17.2 ± N/A (8) | 50.3± 4.2 (8) | 50.3 ± 4.1 (8) | 15,769 | 58 |
| Caudwell, 2013 [ | Yes | N/A | 5×/week during 12 weeks of continuous walking/biking/running/rowing/stepping machine at 70% HRmax | BP | 33.2 ± 10.4 (35) | 30.1 ± N/A (35) | 63.4 ± 6.5 (35) | 63.5 ± N/A (35) | 29,339 | 0 |
| Caudwell, 2013 [ | Yes | N/A | 5×/week during 12 weeks of continuous walking/biking/running/rowing/stepping machine at 70% HRmax | BP | 38.3 ± 9.0 (72) | 35.3 ± N/A (72) | 47.7 ± 5.8 (72) | 48.3 ± N/A (72) | 27,547 | 1 |
| Cowan, 1985 [ | No | 93.75 | 4×/week for 17–44 min during 9 weeks of continuous walking at 80% aged predicted HRmax | HW | 21.9 ± N/A (16) | 21.2 ± N/A (16) | 45.6 ± N/A (16) | 46.3 ± N/A (16) | 6001 | 11 |
| Cramer, 1991 [ | Yes | 100 | 5×/week for 45 min during 15 weeks of continuous walking/biking at 62% VO2max | HW | 27.9 ± N/A (18) | 27.8 ± N/A (18) | 48.6 ± N/A (18) | 48.7 ± N/A (18) | 20,810 | 94 |
| Després, 1991 [ | No | N/A | 4.5×/week for 90 min during 61 weeks of continuous walking/biking/aerobic dance/swimming at 55% VO2max | HW | 42.6 ± 9.4 (13) | 38.0 ± 7.3 (13) | 47.4 ± 5.1 (13) | 48.3 ± 4.1 (13) | 163,327 | 74 |
| Donnelly, 2000 [ | Yes | 91.9 | 3×/week for 29 min during 78 weeks of continuous exercise (N/A) at 60%–75% VO2max | HW | 34.0 ± 3.7 (11) | 31.9 ± 3.3 (11) | 47.4 ± 3.7 (11) | 47.8 ± 3.8 (11) | 41,793 | 54 |
| Donnelly, 2000 [ | Not always | 90.3 | 5×/week for 14.5 min twice daily during 78 weeks of continuous walking at 50%–65% HRreserve | HW | 36.7 ± 7.0 (11) | 36.0 ± 7.7 (11) | 49.1 ± 7.7 (11) | 49.1 ± 7.5 (11) | 60,492 | 89 |
| Donnelly, 2013 [ | Yes | >90 | 5×/week for the time necessary to expend 600 kcal/session during 43.5 weeks of continuous biking/running/walking/exercise on elliptical machine at 70%–80% HRmax | DEXA | 34.1 ± 9.4 (18) | 29.7 ± 9.6 (18) | 46.1 ± 5.3 (18) | 46.9 ± 4.8 (18) | 111,703 | 64 |
| Donnelly, 2013 [ | Yes | >90 | 5×/week for the time necessary to expend 400 kcal/session during 43.5 weeks of continuous biking/running/walking/exercise on elliptical machine at 70%–80% HRmax | DEXA | 34.8 ± 11.1 (19) | 31.7 ±12.2 (19) | 46.9 ± 8.0 (19) | 47.0 ± 7.7 (19) | 74,744 | 61 |
| Donnelly, 2013 [ | Yes | >90 | 5×/week for the time necessary to expend 600 kcal/session during 43.5 weeks of continuous biking/running/walking/exercise on elliptical machine at 70%–80% HRmax | DEXA | 36.4 ± 7.5 (19) | 30.5 ± 10.1 (19) | 65.0 ± 7.3 (19) | 65.4 ± 7.4 (19) | 111,703 | 51 |
| Donnelly, 2013 [ | Yes | >90 | 5×/week for the time necessary to expend 400 kcal/session during 43.5 weeks of continuous biking/running/walking/exercise on elliptical machine at 70%–80% HRmax | DEXA | 34.5 ± 11.6 (18) | 31.0 ± 11.4 (18) | 64.4 ± 9.9 (18) | 64.4 ± 9.2 (18) | 74,744 | 56 |
| Dowdy, 1985 [ | No | ≥90 | 3×/week for 45 min during 10 weeks of continuous aerobic dance at 77% HRreserve | HW | 19.3 ± 6.4 (18) | 19.7 ± 5.8 (18) | 43.8 ± 3.1 (18) | 44.1 ± 2.3 (18) | 11,525 | 146 |
| Earnest, 2013 [ | No | N/A | 3–4×/week during 12 weeks of continuous running/walking at 50%–70% VO2max and running/walking interval between 90% and 95% VO2max with recuperation at 50% VO2max | DEXA | 27.5 ± N/A (21) | 26.1 ± N/A (21) | 66.4 ± N/A (21) | 65.5 ± N/A (21) | 12,096 | −15 |
| Earnest, 2013 [ | No | N/A | 3–4×/week during 12 weeks of continuous running/walking at 50%–70% VO2max | DEXA | 28.3 ± N/A (16) | 27.8 ± N/A (16) | 70.6 ± N/A (16) | 69.9 ± N/A (16) | 12,096 | 50 |
| Glisezinski, 2003 [ | Yes | N/A | 5×/week for 60 min during 17 weeks of continuous running/biking at a VO2max that increased from 50%–85% | DEXA | 20.4 ± N/A (11) | 19.0 ± N/A (11) | 69.1 ± N/A (11) | 68.6 ± N/A (11) | 58,785 | 77 |
| Glowacki, 2004 [ | Yes | N/A | 2–3×/week for 20–40 min during 12 weeks of continuous running at 65%–80% HRreserve | HW | 19.2 ± N/A (12) | 17.3 ± N/A (12) | 68.7 ± 9.5 (12) | 69.5 ± 9.3 (12) | 13,210 | −25 |
| Grediagin, 1995 [ | No | 100 | 4×/week during 12 weeks of continuous exercise on a treadmill at 80% VO2max | HW | 21.2 ± N/A (6) | 18.9 ± N/A (6) | 47.0 ± N/A (6) | 48.9 ± N/A (6) | 14,400 | −24 |
| Grediagin, 1995 [ | No | 100 | 4×/week during 12 weeks of continuous exercise on a treadmill at 50% VO2max | HW | 21.3 ± N/A (6) | 19.0 ± N/A (6) | 47.4 ± N/A (6) | 48.2 ± N/A (6) | 14,400 | −39 |
| Hardman, 1992 [ | No | N/A | ≥3×/week for ˃20 min during 52 weeks of continuous brisk walking | HW | 23.7 ± 1.5 (28) | 24.7 ± 1.6 (28) | 40.3 ± N/A (28) | 39.6 ± N/A (28) | 44,726 | 125 |
| Hinkleman, 1993 [ | Yes | N/A | 5×/week for 45 min during 15 weeks of continuous walking at 60% HRreserve | HW | 28.1 ± 1.4 (18) | 28.0 ± 1.3 (18) | 48.4 ± 0.9 (18) | 48.5 ± 0.9 (18) | 20,139 | 96 |
| Juneau, 1987 [ | No | N/A | 5×/week for 47 min during 24 weeks of continuous exercise (N/A) at 50%–66% VO2max | HW | 17.9 ± N/A (28) | 14.0 ± N/A (28) | 61.5 ± 8.0 (28) | 63.9 ± 13.0 (28) | 38,160 | 15 |
| Juneau, 1987 [ | No | N/A | 5×/week for 54 min during 24 weeks of continuous exercise (N/A) at 50%–66% VO2max | HW | 17.8 ± N/A (24) | 16.6 ± N/A (24) | 46.0 ± 5.0 (24) | 46.8 ± 4.0 (24) | 30,960 | 68 |
| Kirk, 2003 [ | Yes | 89.6 | 3–5×/week for 20–45 min during 70 weeks of continuous biking/walking/aerobic exercise in water at a VO2max that increased from 55%–70% | HW | 27.4 ± 7.1 (25) | 27.2 ± 7.9 (25) | 49.5 ± 5.8 (25) | 50.4 ± 5.8 (25) | 118,837 | 100 |
| Kirk, 2003 [ | Yes | 90.3 | 3–5×/week for 20–45 min during 70 weeks of continuous biking/walking/aerobic exercise in water at a VO2max that increased from 55%–70% | HW | 26.8 ± 6.8 (16) | 21.9 ± 5.5 (16) | 67.1 ± 8.3 (16) | 66.9 ± 7.8 (16) | 177,717 | 74 |
| Krustrup, 2010 [ | No | 90 | 2×/week for 60 min during 16 weeks of soccer at 83% HRmax | DEXA | 25.6 ± 1.4 (21) | 24.2 ± 1.5 (21) | 42.5 ± 1.2 (21) | 43.9 ± 1.3 (21) | 16,055 | 33 |
| Krustrup, 2010 [ | No | 92.5 | 2×/week for 60 min during 16 weeks of continuous running at 82% HRmax | DEXA | 22.0 ± 1.7 (17) | 20.9 ± 1.6 (17) | 41.6 ± 0.8 (17) | 42.9 ± 0.8 (17) | 16,055 | 50 |
| Krustrup, 2009 [ | No | 92 | 2.3×/week for 60 min during 12 weeks of soccer at 82% HRmax | DEXA | 19.9 ± 2.4 (12) | 17.2 ± 2.1 (12) | 57.7 ± 2.2 (12) | 59.4 ±1.9 (12) | 19,783 | −13 |
| Krustrup, 2009 [ | No | 100 | 2.5×/week for 60 min during 12 weeks of continuous running at 82% HRmax | DEXA | 20.7 ± 2.7 (10) | 19.0 ± 2.6 (10) | 61.3 ± 2.8 (10) | 61.9 ± 2.7 (10) | 21,503 | 31 |
| Lee, 2009 [ | Yes | 100 | 3×/week for 25 min during 6 weeks of continuous running at 60% VO2max and then 4×/week for 40 min during the following 6 weeks of continuous running at 80% VO2max | HW | 12.1 ± 1.4 (9) | 11.2 ± 1.4 (9) | 61.7 ± 2.0 (9) | 62.1 ± 2.0 (9) | 18,615 | 58 |
| Moro, 2005 [ | Yes | ≥90 | 5×/week for 45 min (mos1–2) and 60 min (months 3–4) during 17.4 weeks of continuous running/biking at 50%–85% VO2max | DEXA | 20.2 ± N/A (10) | 18.6 ± N/A (10) | 70.1 ± N/A (10) | 68.7 ± N/A (10) | 52,038 | 68 |
| Mougios, 2006 [ | Yes | N/A | 4×/week during 13 weeks of continuous running at 72% VO2max | HW | 21.1 ± 2.9 (7) | 18.8 ± 2.3 (7) | 42.9 ± 4.7 (7) | 43.4 ± 4.7 (7) | 18,500 | −12 |
| Mougios, 2006 [ | Yes | N/A | 4×/week during 13 weeks of continuous running/walking at 45% VO2max | HW | 23.0 ± 5.7 (7) | 20.0 ± 5.9 (7) | 45.7 ± 4.2 (7) | 45.4 ± 4.6 (7) | 18,500 | −54 |
| Nishida, 2010 [ | Yes | 100 | 5×/week for 60 min during 12 weeks of continuous biking at a VO2max that increased from 36.8%–54.8% | HW | 9.1 ± N/A (6) | 8.9 ± N/A (6) | 57.3 ± N/A (6) | 57.6 ± N/A (6) | 25,304 | 95 |
| Nordby, 2012 [ | Not always | 85.6 | 3.5×/week for 51.4 min during 12 weeks of continuous biking at 65% HRreserve and biking/running/rowing/elliptic machine interval at 85% HRreserve | DEXA | 28.5 ± 1.4 (12) | 20.8 ± 1.7 (12) | 66.0 ± 2.0 (12) | 67.8 ± N/A (12) | 24,205 | −186 |
| Nybo, 2010 [ | No | N/A | 2.5×/week for 60 min during 12 weeks of continuous running at 65% VO2max | DEXA | 21.1 ± N/A (9) | 19.5 ± N/A (9) | 61.3 ± 2.8 (9) | 61.9 ± 2.7 (9) | 20,454 | 32 |
| Polak, 2006 [ | Not always | N/A | 5×/week for 45 min during 12 weeks of continuous biking/gymnasium exercise with an increased from 50% to 60% and to 65% VO2peak every 3 weeks | DEXA | 34.3 ± N/A (25) | 30.2 ± N/A (25) | 54.2 ± N/A (25) | 53.1 ± N/A (25) | 17,965 | −120 |
| Rosenkilde, 2012 [ | No | 99 | 6.2×/week for 30 min during 10 weeks of continuous biking/running at 66% VO2peak | DEXA | 30.0 ± 4.6 (18) | 26.0 ± N/A (18) | 63.3 ± 6.9 (18) | 63.6 ± N/A (18) | 21,105 | −76 |
| Rosenkilde, 2012 [ | No | 96 | 6.2×/week for 55 min during 10 weeks of continuous biking/running at 67% VO2peak | DEXA | 27.4 ± 4.2 (18) | 23.6 ± N/A (18) | 64.0 ± 5.7 (18) | 65.0 ± N/A (18) | 41,139 | 17 |
| Ruby, 1996 [ | Yes | ≥95 | 4×/week for 45 min during 10 weeks of continuous running at 70%–80% HRreserve | HW | 12.0 ± N/A (6) | 10.5 ± N/A (6) | 46.2 ± N/A (6) | 46.5 ± N/A (6) | 16,686 | 21 |
| Ruby, 1996 [ | Yes | ≥95 | 4×/week for 45 min during 10 weeks of continuous biking at 70%–80% HRreserve | HW | 14.5 ± N/A (6) | 13.5 ± N/A (6) | 47.1 ± N/A (6) | 47.7 ± N/A (6) | 14,936 | 47 |
| Ruby, 1996 [ | Yes | ≥95 | 4×/week for 45 min during 10 weeks of continuous biking/running at 70%–80% HRreserve | HW | 17.5 ± N/A (6) | 17.4 ± N/A (6) | 44.9 ± N/A (6) | 45.4 ± N/A (6) | 16,330 | 101 |
| Santiago, 1995 [ | Yes | 91 | 4×/week during 38 weeks of continuous walking at 72% HRmax | HW | 18.4 ± N/A (16) | 17.0 ± N/A (16) | 46.0 ± N/A (16) | 46.4 ± N/A (16) | 52,440 | 76 |
| Sedlock, 2010 [ | Yes | 100 | 3–4×/week for 25–40 min during 12 weeks of continuous running at a VO2max that increased from 60%–80% | HW | 12.1 ± 1.4 (9) | 11.2 ± 1.4 (9) | 61.7 ± 2.0 (9) | 62.1 ± 2.0 (9) | 16,905 | 54 |
| Sijie, 2012 [ | Yes | N/A | 5×/week for 27 min during 12 weeks of walking (12 min)/running (15 min) interval at 50% and 85% VO2peak | DEXA | 29.9 ± N/A (17) | 24.7 ± N/A (17) | 43.8 ± N/A (17) | 42.8 ± N/A (17) | 14,385 | −248 |
| Sijie 2012 [ | Yes | N/A | 5×/week for 40 min during 12 weeks of continuous running/walking at 50% VO2peak | DEXA | 30.5 ± N/A (16) | 27.2 ± N/A (16) | 43.7 ± N/A (16) | 42.6 ± N/A (16) | 15,003 | −114 |
| Snyder 1997 [ | Not always | 82.6 | 5×/week for 3 × 10 min during 32 weeks of continuous walking at 52% HRreserve | HW | 36.7 ± 14.5 (13) | 37.2 ± 14.7 (13) | 50.6 ± 9.8 (13) | 49.9 ± 10.1 (13) | 19,554 | 128 |
| Suter, 1995 [ | No | N/A 1 | 4×/week for 30 min during 26 weeks of continuous running at 75% VO2max | DEXA | 16.6 ± 6.1 (12) | 15.7 ± 6.4 (12) | 52.9 ± 6.6 (12) | 53.5 ± 6.3 (12) | 36,433 | 80 |
| Tan, 2012 [ | Yes | ≥88 | 5×/week for 40 min during 8 weeks of continuous running at 54% VO2max | DEXA | 31.0 ± 4.6 (29) | 27.0 ± 4.0 (29) | 39.5 ± 4.9 (29) | 39.4 ± 4.4 (29) | 10,797 | −250 |
| Trapp, 2008 [ | No | 100 | 3×/week for 20 min during 15 weeks of biking interval at 53.2% VO2peak power output | DEXA | 22.2 ± 30.0 (11) | 19.7 ± 2.6 (11) | 41.1 ± N/A (11) | 42.1 ± N/A (11) | 9915 | −119 |
| Trapp, 2008 [ | No | 100 | 3×/week for 30 min during 15 weeks of continuous biking at 60% VO2peak | DEXA | 18.4 ± 2.2 (8) | 18.8 ± 2.1 (8) | 41.4 ± N/A (8) | 40.9 ± N/A (8) | 8,673 | 150 |
| Van Aggel-Leijssen, 2002 [ | Yes | 89.4 | 3×/week for 57 min during 12 weeks of continuous biking at 40% VO2max | HW | 32.7 ± N/A (8) | 32.4 ± N/A (8) | 70.0 ± 9.6 (8) | 70.7 ± 8.7 (8) | 12,600 | 87 |
| Van Aggel-Leijssen, 2002 [ | Yes | 92.6 | 3×/week for 33 min during 12 weeks of continuous biking at 70% VO2max | HW | 32.7 ± N/A (8) | 33.3 ± N/A (8) | 72.8 ± 5.4 (8) | 71.8 ± 6.7 (8) | 13,104 | 148 |
| Van Aggel-Leijssen, 2001 [ | Yes | 81 | 3×/week for 57 min during 12 weeks of continuous biking at 40% VO2max | HW | 41.2 ± N/A (8) | 41.7 ± N/A (8) | 50.0 ± 2.4 (8) | 49.5 ± 2.7 (8) | 9000 | 162 |
| Van Aggel-Leijssen, 2001 [ | Yes | 88 | 3×/week for 57 min during 12 weeks of continuous biking at 40% VO2max | HW | 37.1 ± N/A (7) | 37.5 ± N/A (7) | 49.4 ± 3.7 (7) | 49.6 ± 3.8 (7) | 8892 | 158 |
| Wilmore, 1980 [ | No | 99.1 | 3×/week for 30 min during 20 weeks of continuous biking at 75% HRreserve | HW | 19.3 ± N/A (9) | 18. 0 ± N/A (9) | 66.4 ± N/A (9) | 67.4 ± N/A (9) | 23,978 | 56 |
| Wilmore, 1980 [ | No | 93.3 | 3×/week for 30 min during 20 weeks of continuous running at 75% HRreserve | HW | 16.2 ± N/A (9) | 14.5 ± N/A (9) | 63.6 ± N/A (9) | 63.5 ± N/A (9) | 24,239 | 34 |
The values are the mean ± SD. The number in parentheses represents the number of participants tested. Notes: HRRmax, heart rate reserve maximal; HRmax, heart rate maximal; HW, hydrostatic weighing; DEXA, dual X-ray absorptiometry; BP, Bod Pod; 1 compliance minimum of 60 min/week.
Figure 1Flow diagram of the screening process. From the 89 studies selected, 71 were from original studies and 18 were from secondary data analyses of the 71 papers that were included. From the 71 studies, 61 groups were used in the final analysis. For these 61 groups, results were presented for each sex (n = 26 male; n = 35 female), and body composition was measured with either dual-X-ray absorptiometry (DEXA), hydrostatic weighing or bod pod. Only articles with a mean age or with a small range of age (i.e., [19,20,21,22,23]) were kept for further investigation. One group was discarded because the frequency was not mentioned in the article.
Figure 2Correlation between age and initial FM. The median of age = 31 years old; the median for initial FM in studies involving younger subjects = 20.8 kg; and the median for older subjects = 27.5 kg. There were n = 15 studies in all groups, except for the group of older subjects with a high initial FM (n = 16 studies).
Figure 3Degree of energy compensation illustrated as the interaction between age and initial FM of individuals, as well as with the duration of each exercise intervention. Each exercise intervention study is represented by a symbol.